Document
IPR2023-00724, No. 1044 Exhibit - Rohatagi (P.T.A.B. Mar. 16, 2023)
Cite Document
IPR2023-00724, No. 1044 Exhibit - Rohatagi (P.T.A.B. Mar. 16, 2023)
+ More Snippets
Document
IPR2023-00724, No. 1032 Exhibit - Knudsen 2004 (P.T.A.B. Mar. 16, 2023)
Cite Document
IPR2023-00724, No. 1032 Exhibit - Knudsen 2004 (P.T.A.B. Mar. 16, 2023)
+ More Snippets
Document
IPR2023-00724, No. 1018 Exhibit - Banting 1922 (P.T.A.B. Mar. 16, 2023)
Cite Document
IPR2023-00724, No. 1018 Exhibit - Banting 1922 (P.T.A.B. Mar. 16, 2023)
+ More Snippets
Document
IPR2023-00724, No. 1013 Exhibit - NCT657 (P.T.A.B. Mar. 16, 2023)
Cite Document
IPR2023-00724, No. 1013 Exhibit - NCT657 (P.T.A.B. Mar. 16, 2023)
+ More Snippets
Document
IPR2023-00724, No. 1002 Exhibit - 462 file history (P.T.A.B. Mar. 16, 2023)
Cite Document
IPR2023-00724, No. 1002 Exhibit - 462 file history (P.T.A.B. Mar. 16, 2023)
+ More Snippets
Document
IPR2023-00724, No. 1035 Exhibit - Lund 2011 (P.T.A.B. Mar. 16, 2023)
Cite Document
IPR2023-00724, No. 1035 Exhibit - Lund 2011 (P.T.A.B. Mar. 16, 2023)
+ More Snippets
Document
IPR2023-00724, No. 1075 Exhibit - US7022674 (P.T.A.B. Mar. 16, 2023)
Cite Document
IPR2023-00724, No. 1075 Exhibit - US7022674 (P.T.A.B. Mar. 16, 2023)
+ More Snippets
Document
IPR2023-00724, No. 1096 Exhibit - Exhibit 1096 Astrup (P.T.A.B. May. 22, 2024)
Cite Document
IPR2023-00724, No. 1096 Exhibit - Exhibit 1096 Astrup (P.T.A.B. May. 22, 2024)
+ More Snippets
Document
IPR2023-00724, No. 1108 Exhibit - Exhibit 1108 White (P.T.A.B. May. 22, 2024)
Cite Document
IPR2023-00724, No. 1108 Exhibit - Exhibit 1108 White (P.T.A.B. May. 22, 2024)
+ More Snippets
Document
IPR2023-00724, No. 1109 Exhibit - Exhibit 1109 Grunberger (P.T.A.B. May. 22, 2024)
Cite Document
IPR2023-00724, No. 1109 Exhibit - Exhibit 1109 Grunberger (P.T.A.B. May. 22, 2024)
+ More Snippets
Document
IPR2023-00724, No. 2113 Exhibit - EX2113 Victoza® FDA Approval Letter Jan 25, 2010 (P.T.A.B. Jan. 17, 2024)
Cite Document
IPR2023-00724, No. 2113 Exhibit - EX2113 Victoza® FDA Approval Letter Jan 25, 2010 (P.T.A.B. Jan. 17, 2024)
+ More Snippets
Document
IPR2023-00724, No. 2073 Exhibit - EX2073 Novo Nordisk’s Ozempic 05 mg solution for injection in pre filled pen, available at httpswwwmedicinesorgukemcproduct9750smpcgref last visited Jan...
Cite Document
IPR2023-00724, No. 2073 Exhibit - EX2073 Novo Nordisk’s Ozempic 05 mg solution for injection in pre filled pen, available at httpswwwmedicinesorgukemcproduct9750smpcgref last visited January 12, 202
+ More Snippets
Document
IPR2023-00724, No. 2062 Exhibit - EX2062 Rosenstock, J, et al, “Potential of Albiglutide, a Long Acting GLP 1 Receptor Agonist, in Type 2 Diabetes,” Diabetes Care, Vol32, Issue 10, 1880 1886...
Cite Document
IPR2023-00724, No. 2062 Exhibit - EX2062 Rosenstock, J, et al, “Potential of Albiglutide, a Long Acting GLP 1 Receptor Agonist, in Type 2 Diabetes,” Diabetes Care, Vol32, Issue 10, 1880 1886 October
+ More Snippets
Document
IPR2023-00724, No. 2433 Exhibit - EX2433 US Food Drug Administration, DrugsFDA, Invokana® (P.T.A.B. Jan. 17, 2024)
Cite Document
IPR2023-00724, No. 2433 Exhibit - EX2433 US Food Drug Administration, DrugsFDA, Invokana® (P.T.A.B. Jan. 17, 2024)
+ More Snippets
Document
IPR2023-00724, No. 2428 Exhibit - EX2428 Kazano® Prescribing Information rev Feb 2017 (P.T.A.B. Jan. 17, 2024)
Cite Document
IPR2023-00724, No. 2428 Exhibit - EX2428 Kazano® Prescribing Information rev Feb 2017 (P.T.A.B. Jan. 17, 2024)
+ More Snippets